KDM6B and cardiac hypertrophy: The overexpression of JMJD3 promotes cardiomyocyte hypertrophy; JMJD3 silencing or the administration of GSK-J4 (its inhibitor) suppresses ISO-induced cardiac hypertrophy (163).